207 related articles for article (PubMed ID: 7681524)
1. Genotoxic effects of selected peroxisome proliferators.
Reisenbichler H; Eckl PM
Mutat Res; 1993 Apr; 286(2):135-44. PubMed ID: 7681524
[TBL] [Abstract][Full Text] [Related]
2. Induction of sister chromatid exchange and micronuclei in primary cultures of rat and human hepatocytes by the peroxisome proliferator, Wy-14,643.
Hwang JJ; Hsia MT; Jirtle RL
Mutat Res; 1993 Apr; 286(2):123-33. PubMed ID: 7681523
[TBL] [Abstract][Full Text] [Related]
3. Induction of peroxisomal acyl CoA oxidase activity and lipid peroxidation in primary rat hepatocyte cultures.
Tomaszewski KE; Heindel SW; Jenkins WL; Melnick RL
Toxicology; 1990 Dec; 65(1-2):49-60. PubMed ID: 2274969
[TBL] [Abstract][Full Text] [Related]
4. On the mechanism of the hepatocarcinogenicity of peroxisome proliferators.
Nilsson R; Beije B; Préat V; Erixon K; Ramel C
Chem Biol Interact; 1991; 78(2):235-50. PubMed ID: 2040027
[TBL] [Abstract][Full Text] [Related]
5. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.
Wilson MW; Lay LT; Chow CK; Tai HH; Robertson LW; Glauert HP
Arch Toxicol; 1995; 69(7):491-7. PubMed ID: 8526745
[TBL] [Abstract][Full Text] [Related]
6. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators.
Tomaszewski KE; Agarwal DK; Melnick RL
Carcinogenesis; 1986 Nov; 7(11):1871-6. PubMed ID: 3769136
[TBL] [Abstract][Full Text] [Related]
7. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.
Reddy JK; Reddy MK; Usman MI; Lalwani ND; Rao MS
Environ Health Perspect; 1986 Mar; 65():317-27. PubMed ID: 3709457
[TBL] [Abstract][Full Text] [Related]
8. Hypolipidaemic drugs are activated to acyl-CoA esters in isolated rat hepatocytes. Detection of drug activation by human liver homogenates and by human platelets.
Bronfman M; Morales MN; Amigo L; Orellana A; Nuñez L; Cárdenas L; Hidalgo PC
Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):289-95. PubMed ID: 1599408
[TBL] [Abstract][Full Text] [Related]
9. Detection of a nafenopin-binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds.
Lalwani ND; Fahl WE; Reddy JK
Biochem Biophys Res Commun; 1983 Oct; 116(2):388-93. PubMed ID: 6651818
[TBL] [Abstract][Full Text] [Related]
10. Genotoxic properties of 4-hydroxyalkenals and analogous aldehydes.
Eckl PM; Ortner A; Esterbauer H
Mutat Res; 1993 Dec; 290(2):183-92. PubMed ID: 7694109
[TBL] [Abstract][Full Text] [Related]
11. Rodent hepatocarcinogenic peroxisome proliferators induce proliferation of rat hepatocytes in primary mixed cultures with rat liver epithelial cells.
Perrone CE; Williams GM
Cancer Lett; 1998 Jan; 123(1):27-33. PubMed ID: 9461014
[TBL] [Abstract][Full Text] [Related]
12. Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation.
Rao MS; Subbarao V
Fundam Appl Toxicol; 1997 Jan; 35(1):78-83. PubMed ID: 9024675
[TBL] [Abstract][Full Text] [Related]
13. Induction of rat liver DNA alterations by chronic administration of peroxisome proliferators as detected by 32P-postlabeling.
Randerath E; Randerath K; Reddy R; Danna TF; Rao MS; Reddy JK
Mutat Res; 1991 Mar; 247(1):65-76. PubMed ID: 2002806
[TBL] [Abstract][Full Text] [Related]
14. Assessment of peroxisome proliferation and liver growth-stimulating potential by nondirectly genotoxic compounds in cultured hepatocytes.
Bieri F; Stäubli W; Kelly S; Waechter F; Bentley P
Mol Toxicol; 1987-1988 Fall; 1(4):439-44. PubMed ID: 3151502
[TBL] [Abstract][Full Text] [Related]
15. Reduction of the concentrations of prostaglandins E2 and F2alpha, and thromboxane B2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate.
Leung LK; Glauert HP
Toxicol Lett; 1996 Jun; 85(3):143-9. PubMed ID: 8644126
[TBL] [Abstract][Full Text] [Related]
16. Calcium as a permissive factor but not an initiation factor in DNA synthesis induction in cultured rat hepatocytes by the peroxisome proliferator ciprofibrate.
Bennett AM; Williams GM
Biochem Pharmacol; 1993 Dec; 46(12):2219-27. PubMed ID: 8274155
[TBL] [Abstract][Full Text] [Related]
17. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
Perrone CE; Shao L; Williams GM
Toxicol Appl Pharmacol; 1998 Jun; 150(2):277-86. PubMed ID: 9653058
[TBL] [Abstract][Full Text] [Related]
18. Effects of the peroxisome proliferator ciprofibrate and prostaglandin F2 alpha combination treatment on second messengers in cultured rat hepatocytes.
Hong JT; Yun YP
Arch Pharm Res; 1998 Apr; 21(2):120-7. PubMed ID: 9875418
[TBL] [Abstract][Full Text] [Related]
19. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat.
Graham MJ; Winham MA; Old SL; Gray TJ
Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis.
Yeldandi AV; Milano M; Subbarao V; Reddy JK; Rao MS
Cancer Lett; 1989 Sep; 47(1-2):21-7. PubMed ID: 2636030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
